Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Chronic Heart Failure

  Free Subscription


3 Am Heart J
1 Am J Cardiol
1 Circ Heart Fail
1 Clin Cardiol
2 Eur Heart J
4 Eur J Heart Fail
5 Heart
7 Int J Cardiol
1 J Am Coll Cardiol
2 J Card Fail
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. FAXEN J, Benson L, Mantel A, Savarese G, et al
    Association Between Rheumatoid Arthritis and Incident Heart Failure by Left Ventricular Ejection Fraction.
    Am Heart J. 2023 Feb 9:S0002-8703(23)00035-2. doi: 10.1016/j.ahj.2023.
    PubMed         Abstract available

  2. LIU J, Wang B, Li Y, Yan X, et al
    Rationale and design of the Effects of intensive Systolic blood Pressure lowering treatment in reducing RIsk of vascular evenTs (ESPRIT): a multicenter open-label randomized controlled trial.
    Am Heart J. 2022 Dec 6:S0002-8703(22)00322-2. doi: 10.1016/j.ahj.2022.
    PubMed         Abstract available

  3. OMEROVIC E, James S, Erlinge D, Hagstrom H, et al
    Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome.
    Am Heart J. 2023;257:33-40.
    PubMed         Abstract available

    Am J Cardiol

  4. ITZHAKI BEN ZADOK O, Nardi Agmon I, Neiman V, Eisen A, et al
    Implantable Cardioverter Defibrillator for the Primary Prevention of Sudden Cardiac Death among Patients With Cancer.
    Am J Cardiol. 2023;191:32-38.
    PubMed         Abstract available

    Circ Heart Fail

  5. LUBERT AM, Cedars A, Almond CS, Amdani S, et al
    Considerations for Advanced Heart Failure Consultation in Individuals With Fontan Circulation: Recommendations From ACTION.
    Circ Heart Fail. 2023 Feb 14:e010123. doi: 10.1161/CIRCHEARTFAILURE.122.010123.
    PubMed         Abstract available

    Clin Cardiol

  6. CHEN W, Lin G, Dai C, Xu K, et al
    Predictive value of serum iron on heart failure in patients with acute ST-segment elevation myocardial infarction.
    Clin Cardiol. 2023 Feb 13. doi: 10.1002/clc.23990.
    PubMed         Abstract available

    Eur Heart J

  7. VERGALLO R, Pedicino D
    Intravenous ferric derisomaltose for patients with heart failure: does iron heart translate into IRONMAN?
    Eur Heart J. 2023 Feb 14:ehad076. doi: 10.1093.

  8. Corrigendum to: Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).
    Eur Heart J. 2023 Feb 14:ehad059. doi: 10.1093.

    Eur J Heart Fail

  9. Correction to: "A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry" and articles listed below.
    Eur J Heart Fail. 2023 Feb 17. doi: 10.1002/ejhf.2789.

  10. MICHOU E, Wussler D, Mueller C
    Reply to the Letter to the Editor regarding the article "Quantifying inflammation using Interleukin-6 for improved phenotyping and risk stratification in acute heart failure".
    Eur J Heart Fail. 2023 Feb 15. doi: 10.1002/ejhf.2802.

  11. LONCAR G, Garfias-Veitl T, Valentova M, Vatic M, et al
    Bone status in men with heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure.
    Eur J Heart Fail. 2023 Feb 13. doi: 10.1002/ejhf.2794.
    PubMed         Abstract available

  12. CAPPELLETTO C, Stolfo D, Orsini N, Benson L, et al
    Use of and Association between Heart Failure Pharmacological Treatments and Outcomes in Obese vs. non-Obese Patients with Heart Failure with Reduced Ejection Fraction: Data from the Swedish Heart Failure Registry.
    Eur J Heart Fail. 2023 Feb 13. doi: 10.1002/ejhf.2795.
    PubMed         Abstract available


  13. EDWARD J, Banchs J, Parker H, Cornwell W, et al
    Right ventricular function across the spectrum of health and disease.
    Heart. 2023;109:349-355.
    PubMed         Abstract available

  14. WEBER C, Hung J, Hickling S, Li I, et al
    Emergent readmission and long-term mortality risk after incident atrial fibrillation hospitalisation.
    Heart. 2022 Nov 16. pii: heartjnl-2022-321560. doi: 10.1136/heartjnl-2022-321560
    PubMed         Abstract available

  15. PINTO-FILHO MM, Soares CPM, Paixao GM, Ribeiro ALP, et al
    Response to: Correspondence on "Electrocardiographic findings and prognostic values in patients hospitalised with COVID-19 in the World Heart Federation Global Study" by Marateb et al.
    Heart. 2023;109:414-415.

  16. MARATEB HR, Mansourian M, Mananas MA
    Correspondence on "Electrocardiographic findings and prognostic values in patients hospitalised with COVID-19 in the World Heart Federation Global Study" by Pinto-Filho et al.
    Heart. 2023;109:413-414.

  17. NORHAMMAR A, Bodegard J, Vanderheyden M, Tangri N, et al
    Prevalence, outcomes and costs of a contemporary, multinational population with heart failure.
    Heart. 2023 Feb 13:heartjnl-2022-321702. doi: 10.1136/heartjnl-2022-321702.
    PubMed         Abstract available

    Int J Cardiol

  18. LI X, Shen Y, Xu X, Guo G, et al
    Genomic and RNA-Seq profiling of patients with HFrEF unraveled OAS1 mutation and aggressive expression.
    Int J Cardiol. 2023;375:44-54.
    PubMed         Abstract available

  19. ZHANG HD, Yan Y, He YY, Liu QQ, et al
    Characteristics of exercise intolerance in different subgroups of pulmonary arterial hypertension associated with congenital heart disease.
    Int J Cardiol. 2023;375:29-35.
    PubMed         Abstract available

  20. CAMPBELL-QUINTERO S, Echeverria LE, Gomez-Mesa JE, Rivera-Toquica A, et al
    Comorbidity profile and outcomes in patients with chronic heart failure in a Latin American country: Insights from the Colombian heart failure registry (RECOLFACA).
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00236.
    PubMed         Abstract available

  21. GOES-SANTOS BR, Rondon E, Fonseca GWP, Sales ARK, et al
    Physical capacity increase in patients with heart failure is associated with improvement in muscle sympathetic nerve activity.
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00234.
    PubMed         Abstract available

  22. YANAGISAWA S, Inden Y, Murohara T
    Catheter ablation for atrial fibrillation in heart failure: Getting closer to the full picture in the whole population.
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00226.

  23. KERSTENS TP, Weerts J, van Dijk APJ, Weijers G, et al
    Left ventricular strain-volume loops and diastolic dysfunction in suspected heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Feb 14:S0167-5273(23)00167.
    PubMed         Abstract available

  24. NISHINO M, Egami Y, Kawanami S, Sugae H, et al
    Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Feb 14:S0167-5273(23)00237.
    PubMed         Abstract available

    J Am Coll Cardiol

  25. WECKBACH LT, Stolz L, Chatfield AG, Fam NP, et al
    Right Ventricular Reverse Remodeling After Transcatheter Tricuspid Valve Replacement in Patients With Heart Failure.
    J Am Coll Cardiol. 2023;81:708-710.

    J Card Fail

  26. MENTZ RJ, Ward JH, Hernandez AF, LePage S, et al
    Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/valsartan versus Valsartan in HFmrEF and HFpEF with a Worsening Heart Failure Event.
    J Card Fail. 2023 Feb 14:S1071-9164(23)00040.
    PubMed         Abstract available

  27. MIAO F, Wang B, Zhang L, Yan X, et al
    Distinct associations between post-discharge cognitive change patterns and 1-year outcomes in patients hospitalized for heart failure.
    J Card Fail. 2023 Feb 8:S1071-9164(23)00035.
    PubMed         Abstract available

    PLoS One

  28. SONG Y, Leem J, Dhanani M, McKirnan MD, et al
    Impact of blood factors on endothelial cell metabolism and function in two diverse heart failure models.
    PLoS One. 2023;18:e0281550.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.